Towards tailored chemotherapy for NSCLC
This article has no abstract so we have provided the first paragraph of the full text.
An individual's response to chemotherapy may be influenced by single nucleotide polymorphisms (SNPs) at a variety of loci. Isla and colleagues from the Spanish Lung Cancer Group have considered whether SNPs in four relevant genes (ERCC1, XPD, RRM1 and MDR1) predict survival in non-small-cell lung cancer (NSCLC) patients treated with docetaxel–cisplatin.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Mathematical physics Added dimensions to grain growthNature News and Views (26 Apr 2007)